Louisiana Business Tribune
SEE OTHER BRANDS

Fresh news on business and economy in Louisiana

Louisiana Business Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Business Tribune.

Press releases published on May 2, 2025

Flow Force Max Under Review: Natural Chewable Candy Ingredients to Support Prostate Health for Men

Flow Force Max Under Review: Natural Chewable Candy Ingredients to Support Prostate Health for Men

New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why FlowForce Max is gaining attention as a complete, natural prostate support supplement for men over 40 How FlowForce Max uses a 3-phase male vitality protocol to target …

Fluxactive Under Review: The Complete Prostate Wellness Formula for Bladder Support

Fluxactive Under Review: The Complete Prostate Wellness Formula for Bladder Support

New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What Fluxactive Complete is and how it supports long-term prostate health naturally The full list of Fluxactive Complete ingredients and how each one contributes to better urinary …

EyeFortin Under Review: Powerful Vision Supporting Formula for Optimal Eyesight Health

EyeFortin Under Review: Powerful Vision Supporting Formula for Optimal Eyesight Health

New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The hidden impact of artificial light and blue light on vision and the eye-brain connection How EyeFortin supports visual processing by targeting glutamate receptors in the brain …

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Company Announcement Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual primary endpoints in the Phase 3 EPCORE® FL-1 trial Full results from the trial will be submitted for presentation at an upcoming …

MD/Process MitoThrive Under Review: The Cellular Refuelling Technique with NAD Precursor Nicotinamide Riboside

MD/Process MitoThrive Under Review: The Cellular Refuelling Technique with NAD Precursor Nicotinamide Riboside

New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why signs of aging like fatigue, dull skin, and brain fog may be linked to declining NAD+ levels How cellular energy and mitochondrial health directly impact overall vitality and …

Fast Lean Pro Under Review: Best Intermittent Fasting Support Supplement for Healthy Weight Loss

Fast Lean Pro Under Review: Best Intermittent Fasting Support Supplement for Healthy Weight Loss

New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why traditional weight loss methods often fail despite diet and exercise How intermittent fasting triggers the body’s natural fat-burning and cellular renewal mechanisms The …

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

MANAUS, Brazil, May 01, 2025 (GLOBE NEWSWIRE) -- Brazil Potash Corp. ("Brazil Potash" or the "Company") (NYSE-American: GRO), a mineral exploration and development company with a critical mineral potash mining project, the Autazes Project, today announced …

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Faircourt Gold Income Corp. Announces Net Asset Value for Annual Redemption of Class A Shares

Toronto, May 01, 2025 (GLOBE NEWSWIRE) -- Faircourt Asset Management Inc., the Manager of Faircourt Gold Income Corp. (the “Company”) announces today that Securityholders who tendered their Class A Shares for redemption on March 31, 2025 will be entitled …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service